Pharmaceutical Industry

The innovative Pharmaceutical industry in the United States produces chemically-derived drugs developed as a result of extensive R&D and Clinical trials in both humans and animals.  The innovator relies on patents and other forms of intellectual property rights to justify the investment required to bring a product to market (the U.S. patent term is 20 years).  Several large multinationals produce the majority of innovative pharmaceuticals globally, but they have come to rely more heavily on research performed by industry partners, including smaller, innovative manufacturers.  Pricing of innovative pharmaceuticals is designed to recapture R&D expenditures.

  • Drug Discovery
  • Pharmaceutical Packaging
  • Quality Control
  • Quality Assurance
  • GMP & cGMP
  • Quality by Design
  • Quality Risk Assessment

Related Conference of Pharmaceutical Industry

April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Paris, France
August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Aix-en-Provence, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Pharmaceutical Industry Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in